Expanding medical marijuana access in Canada: Considerations for the rheumatologist

Journal of Rheumatology

Volumn 42, Issue 2, 2015, Pages 143-145

  Fitzcharles, Mary Ann ^a,b,d   Jamal Md, Shahin ^c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; MEDICAL CANNABIS;

ADVERSE OUTCOME; ANALGESIA; CANADA; DRUG CONTROL; DRUG SAFETY; EDITORIAL; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; NICOTIANA TABACUM; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; HEALTH CARE DELIVERY; RHEUMATOLOGY;

CANADA; HEALTH SERVICES ACCESSIBILITY; HUMANS; MEDICAL MARIJUANA; RHEUMATOLOGY;

EID: 84923195755     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.131514     Document Type: Editorial

References (19)

1. Charlton A. Medicinal uses of tobacco in history. J R Soc Med 2004;97:292-6.
2. Kalant H. Medicinal use of cannabis: history and current status. Pain Res Manage 2001;6:80-91.
3. Government of Canada. Marihuana Medical Access Regulations. Minister of Justice. [Internet. Accessed August 3, 2014.] Available from: http://laws-lois.justice.gc.ca
4. Government of Canada. Marihuana for Medical Purposes Regulations. Minister of Justice. [Internet. Accessed August 3, 2014.] Available from: http://laws-lois.justice.gc.ca/eng/ regulations/SOR-2013-119/index.html#
5. Office of the Information Commissioner of Canada, Information request (ATI 2013-00282) under the Access to Information Act, 2013.
6. Goldenberg, DL, Clauw DJ, Fitzcharles MA. New concepts in pain research and pain management of the rheumatic diseases. Semin Arthritis Rheum 2011;41:319-34.
7. Richardson D, Pearson RG, Kurian N, Latif ML, Garle MJ, Barrett DA, et al. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 2008;10:R43.
8. Schuelert N, McDougall JJ. Cannabinoid-mediated antinociception is enhanced in rat osteoarthritic knees. Arthritis Rheum 2008;58:145-53.
9. Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg 2010;110:604-610.
10. Swift W, Gates P, Dillon P. Survey of Australians using cannabis for medical purposes. Harm Reduct J 2005;2:18.
11. Ware MA, Adams H, Guy GW. The medicinal use of cannabis in the UK: results of a nationwide survey. Int J Clin Pract 2005;59:291-5.
12. Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology 2006;45:50-2.
13. Skrabek RQ, Galimova L, Ethans K, Perry D. Nabilone for the treatment of pain in fibromyalgia. J Pain 2008;9:164-73.
14. Fitzcharles MA, McDougall J, Ste-Marie PA, Padjen I. Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm? Arthritis Rheum 2012;64:2417-25.
15. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:849-63.
16. Mensinga TT, de Vries I, Kruidenier M, Hunault CC, van den Hengel-Koot IS, Fijen JW, et al. A double-blind, randomized, placebo-controlled, cross-over study on the pharmacokinetics and effects of cannabis. [Internet. Accessed June 4, 2014.] Available from: rivm.openrepository.com/rivm/bitstream/10029/ 7272/1/267002002.pdf
17. Fletcher J. Marijuana is not a prescription medicine. CMAJ 2013;185:369.
18. Health Canada, Information for Health Care Professionals -Cannabis and the Cannabinoids, Health Canada Controlled Substances and Tobacco Directorate, Editor 2013.
19. Fitzcharles MA, Ste-Mariel PA, Clauw DJ, Jamal S, Karsh J, Leclercq S, et al. Rheumatologists lack confidence in knowledge of cannabinoids in the management of rheumatic conditions: a needs assessment of Canadian rheumatologists [abstract]. Arthritis Rheum 2013;65 Suppl:S49.